##issue.return##
CARDIOPROTECTIVE MECHANISMS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ISCHEMIC HEART DISEASE
##common.download##
##common.downloadPdf##